Impel Pharmaceuticals Inc... (IMPL)
NASDAQ: IMPL
· Real-Time Price · USD
0.04
-0.01 (-27.27%)
At close: Dec 20, 2023, 8:58 PM
Impel Pharmaceuticals Revenue
Impel Pharmaceuticals reported an annual revenue of $12.65M, reflecting a 1794.01% growth. For the quarter ending September 30, 2023, Impel Pharmaceuticals generated $5.02M in revenue.
Revenue (ttm)
$12.65M
Revenue Growth
1794.01%
Price / Sales Ratio
6.95
Revenue / Employee
$79.08K
Employees
160
Market Cap
956K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|